Revenues Down and Stock Battered as Data Firm Faces Scrutiny

By Chris Hamby from NYT Health https://ift.tt/7IRgcYO
https://ift.tt/7IRgcYO

How Did Mpox Become a Global Emergency? What’s Next?

By Apoorva Mandavilli from NYT Health https://ift.tt/LTadBMt
https://ift.tt/LTadBMt

Unresponsive Brain-Damaged Patients May Have Some Awareness

By Carl Zimmer from NYT Health https://ift.tt/DdO2BsG
https://ift.tt/DdO2BsG

W.H.O. Declares Global Emergency Over New Mpox Outbreak

By Apoorva Mandavilli from NYT Health https://ift.tt/2QhE7kw
https://ift.tt/2QhE7kw

Hot Summer Threatens Efficacy of Mail-Order Medications

By Emily Baumgaertner from NYT Health https://ift.tt/NHe2mcx
https://ift.tt/NHe2mcx

Older Adults Do Not Benefit From Moderate Drinking, Large Study Finds

By Roni Caryn Rabin from NYT Health https://ift.tt/A2xMusv
https://ift.tt/A2xMusv

Three Studies of MDMA Treatment Retracted by Scientific Journal

By Andrew Jacobs from NYT Health https://ift.tt/g0VnBk4
https://ift.tt/g0VnBk4

I.V.F. Threats in Alabama Drive Clinics to Ship Out Embryos

By Azeen Ghorayshi and Sarah Kliff from NYT Health https://ift.tt/lDy3M1s
https://ift.tt/lDy3M1s

What Killed Harmony Ball-Stribling?

By Roni Caryn Rabin and Rory Doyle from NYT Health https://ift.tt/n2tV4YT
https://ift.tt/n2tV4YT

F.D.A. Declines to Approve MDMA Therapy, Seeking More Study

By Andrew Jacobs from NYT Health https://ift.tt/hVX5txM
https://ift.tt/hVX5txM